Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse

Gary H Wynn; Kelly L Cozza; Michael J Zapor; Glenn W Wortmann; Scott C Armstrong

doi:10.1176/appi.psy.46.1.79

Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse

Gary H Wynn, Kelly L Cozza, Michael J Zapor, Glenn W Wortmann, Scott C Armstrong

Psychiatry

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Abstract

The third in a series reviewing the HIV/AIDS antiretroviral drugs, this report summarizes the interactions between antiretrovirals and common drugs of abuse. In an overview format for primary care physicians and psychiatrists, the metabolism and drug interactions in the context of antiretroviral therapy are presented for the following drugs of abuse: alcohol, benzodiazepines, cocaine, GHB (liquid X), ketamine (special K), LSD (acid), MDMA (Ecstasy), opiates, PCP (angel dust), and THC (marijuana).

Original language	English
Pages (from-to)	79-87
Number of pages	9
Journal	Psychosomatics
Volume	46
Issue number	1
DOIs	https://doi.org/10.1176/appi.psy.46.1.79
State	Published - 2005

Keywords

Acquired Immunodeficiency Syndrome/drug therapy
Anti-Retroviral Agents/administration & dosage
Cytochrome P-450 Enzyme System/metabolism
Drug Interactions
Enzyme Induction/drug effects
HIV Infections/drug therapy
Humans
Illicit Drugs/adverse effects
Patient Compliance
Patient Education as Topic

Access to Document

10.1176/appi.psy.46.1.79

Cite this

@article{0da2898e7baf411ea4ad4aeb536f4a3a,

title = "Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse",

abstract = "The third in a series reviewing the HIV/AIDS antiretroviral drugs, this report summarizes the interactions between antiretrovirals and common drugs of abuse. In an overview format for primary care physicians and psychiatrists, the metabolism and drug interactions in the context of antiretroviral therapy are presented for the following drugs of abuse: alcohol, benzodiazepines, cocaine, GHB (liquid X), ketamine (special K), LSD (acid), MDMA (Ecstasy), opiates, PCP (angel dust), and THC (marijuana).",

keywords = "Acquired Immunodeficiency Syndrome/drug therapy, Anti-Retroviral Agents/administration & dosage, Cytochrome P-450 Enzyme System/metabolism, Drug Interactions, Enzyme Induction/drug effects, HIV Infections/drug therapy, Humans, Illicit Drugs/adverse effects, Patient Compliance, Patient Education as Topic",

author = "Wynn, {Gary H} and Cozza, {Kelly L} and Zapor, {Michael J} and Wortmann, {Glenn W} and Armstrong, {Scott C}",

year = "2005",

doi = "10.1176/appi.psy.46.1.79",

language = "English",

volume = "46",

pages = "79--87",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc.",

number = "1",

}

TY - JOUR

T1 - Med-psych drug-drug interactions update. Antiretrovirals, part III

T2 - antiretrovirals and drugs of abuse

AU - Wynn, Gary H

AU - Cozza, Kelly L

AU - Zapor, Michael J

AU - Wortmann, Glenn W

AU - Armstrong, Scott C

PY - 2005

Y1 - 2005

N2 - The third in a series reviewing the HIV/AIDS antiretroviral drugs, this report summarizes the interactions between antiretrovirals and common drugs of abuse. In an overview format for primary care physicians and psychiatrists, the metabolism and drug interactions in the context of antiretroviral therapy are presented for the following drugs of abuse: alcohol, benzodiazepines, cocaine, GHB (liquid X), ketamine (special K), LSD (acid), MDMA (Ecstasy), opiates, PCP (angel dust), and THC (marijuana).

AB - The third in a series reviewing the HIV/AIDS antiretroviral drugs, this report summarizes the interactions between antiretrovirals and common drugs of abuse. In an overview format for primary care physicians and psychiatrists, the metabolism and drug interactions in the context of antiretroviral therapy are presented for the following drugs of abuse: alcohol, benzodiazepines, cocaine, GHB (liquid X), ketamine (special K), LSD (acid), MDMA (Ecstasy), opiates, PCP (angel dust), and THC (marijuana).

KW - Acquired Immunodeficiency Syndrome/drug therapy

KW - Anti-Retroviral Agents/administration & dosage

KW - Cytochrome P-450 Enzyme System/metabolism

KW - Drug Interactions

KW - Enzyme Induction/drug effects

KW - HIV Infections/drug therapy

KW - Humans

KW - Illicit Drugs/adverse effects

KW - Patient Compliance

KW - Patient Education as Topic

U2 - 10.1176/appi.psy.46.1.79

DO - 10.1176/appi.psy.46.1.79

M3 - Review article

C2 - 15765827

SN - 0033-3182

VL - 46

SP - 79

EP - 87

JO - Psychosomatics

JF - Psychosomatics

IS - 1

ER -